135 related articles for article (PubMed ID: 33924380)
1. Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials.
Sharma S; Wells JC; Hopman WM; Del Paggio JC; Gyawali B; Hammad N; Hay AE; Booth CM
Curr Oncol; 2021 Apr; 28(2):1518-1527. PubMed ID: 33924380
[TBL] [Abstract][Full Text] [Related]
2. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
Wells JC; Sharma S; Del Paggio JC; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
JAMA Oncol; 2021 Mar; 7(3):379-385. PubMed ID: 33507236
[TBL] [Abstract][Full Text] [Related]
3. Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
Del Paggio JC; Azariah B; Sullivan R; Hopman WM; James FV; Roshni S; Tannock IF; Booth CM
Ann Oncol; 2017 Jan; 28(1):157-162. PubMed ID: 27742650
[TBL] [Abstract][Full Text] [Related]
4. Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience.
Del Paggio JC; Fundytus AM; Hopman WM; Pater JL; Chen BE; Brundage MD; Hay AE; Booth CM
J Natl Cancer Inst; 2021 Oct; 113(10):1422-1428. PubMed ID: 33760057
[TBL] [Abstract][Full Text] [Related]
5. Allocation of authorship and patient enrollment among global clinical trials in oncology.
Rubagumya F; Fundytus A; Keith-Brown S; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Eniu A; Sengar M; Riechelmann RSR; Sullivan R; Booth CM
Cancer; 2023 Sep; 129(18):2856-2863. PubMed ID: 37382190
[TBL] [Abstract][Full Text] [Related]
6. Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income Countries.
Rubagumya F; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Zubaryev M; Eniu A; Tsunoda AT; Kutluk T; Aggarwal A; Sullivan R; Booth CM
JAMA Netw Open; 2022 Aug; 5(8):e2227252. PubMed ID: 35980637
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Long-term Survival Benefits in Trials of Immune Checkpoint Inhibitor vs Non-Immune Checkpoint Inhibitor Anticancer Agents Using ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale.
Everest L; Shah M; Chan KKW
JAMA Netw Open; 2019 Jul; 2(7):e196803. PubMed ID: 31290990
[TBL] [Abstract][Full Text] [Related]
8. Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.
Tibau A; Molto C; Ocana A; Templeton AJ; Del Carpio LP; Del Paggio JC; Barnadas A; Booth CM; Amir E
J Natl Cancer Inst; 2018 May; 110(5):486-492. PubMed ID: 29244173
[TBL] [Abstract][Full Text] [Related]
9. Is Clinical Research Serving the Needs of the Global Cancer Burden? An Analysis of Contemporary Global Radiation Therapy Randomized Controlled Trials.
Dodkins J; Hopman WM; Wells JC; Lievens Y; Malik RA; Pramesh CS; Gyawali B; Hammad N; Mukherji D; Sullivan R; Parkes J; Booth CM; Aggarwal A
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):500-508. PubMed ID: 35151802
[TBL] [Abstract][Full Text] [Related]
10. Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries.
Ndounga Diakou LA; Ntoumi F; Ravaud P; Boutron I
J Clin Epidemiol; 2017 Feb; 82():29-36.e6. PubMed ID: 27865901
[TBL] [Abstract][Full Text] [Related]
11. Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1.
García-Fumero R; Fernández-López C; Calleja-Hernández MÁ; Expósito-Hernández J
Acta Oncol; 2021 Sep; 60(9):1225-1232. PubMed ID: 34184595
[TBL] [Abstract][Full Text] [Related]
12. Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation.
Fundytus A; Wells JC; Sharma S; Hopman WM; Del Paggio JC; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):28-35. PubMed ID: 34479769
[TBL] [Abstract][Full Text] [Related]
13. Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis.
Catalá-López F; Aleixandre-Benavent R; Caulley L; Hutton B; Tabarés-Seisdedos R; Moher D; Alonso-Arroyo A
Trials; 2020 Jan; 21(1):34. PubMed ID: 31910857
[TBL] [Abstract][Full Text] [Related]
14. Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?
Cheng S; McDonald EJ; Cheung MC; Arciero VS; Qureshi M; Jiang D; Ezeife D; Sabharwal M; Chambers A; Han D; Leighl N; Sabarre KA; Chan KKW
J Clin Oncol; 2017 Aug; 35(24):2764-2771. PubMed ID: 28574778
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial in gastric or gastroesophageal junction adenocarcinoma undergoing systemic therapy over two decades.
Xu BB; Lu J; Zheng HL; Xue Z; Zheng CH; Li P; Chen QY; Xie JW; Huang CM
Eur J Surg Oncol; 2023 Oct; 49(10):107007. PubMed ID: 37591026
[TBL] [Abstract][Full Text] [Related]
16. Medical oncology workload in Canada: infrastructure, supports, and delivery of clinical care.
Fundytus A; Hopman WM; Hammad N; Biagi JJ; Sullivan R; Vanderpuye V; Seruga B; Lopes G; Sengar M; Brundage MD; Booth CM
Curr Oncol; 2018 Jun; 25(3):206-212. PubMed ID: 29962838
[TBL] [Abstract][Full Text] [Related]
17. Involvement of low- and middle-income countries in randomized controlled trial publications in oncology.
Wong JC; Fernandes KA; Amin S; Lwin Z; Krzyzanowska MK
Global Health; 2014 Dec; 10():83. PubMed ID: 25498958
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points.
Kay A; Higgins J; Day AG; Meyer RM; Booth CM
Ann Oncol; 2012 Jun; 23(6):1646-51. PubMed ID: 22048151
[TBL] [Abstract][Full Text] [Related]
19. Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity.
Wells JC; Fundytus A; Sharma S; Hopman WM; Del Paggio JC; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
Curr Oncol; 2022 Apr; 29(4):2530-2538. PubMed ID: 35448181
[TBL] [Abstract][Full Text] [Related]
20. Black representation in critical care randomized controlled trials: a meta-epidemiological study.
Tchouambou Youmbi C; Gilman TJ; Ndzana Siani IC; Olaye IE; Popoola AF; Yahya SA; Kyeremanteng K; Gandotra S; Casey JD; Semler MW; Mbuagbaw L; Khalifa A; Rochwerg B
Can J Anaesth; 2023 Jun; 70(6):1064-1074. PubMed ID: 37173564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
